Cargando…
MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial
INTRODUCTION: After deep vein thrombosis, up to 50% of patients develop post-thrombotic syndrome (PTS). PTS is a chronic condition that reduces quality of life (QOL). Cornerstones of PTS treatment include the use of elastic compression stockings but this treatment is usually incompletely effective a...
Autores principales: | Galanaud, Jean Philippe, Abdulrehman, Jameel, Lazo-Langner, A, Le Gal, Grégoire, Shivakumar, Sudeep, Schulman, Sam, Kahn, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438950/ https://www.ncbi.nlm.nih.gov/pubmed/34518263 http://dx.doi.org/10.1136/bmjopen-2021-049557 |
Ejemplares similares
-
TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol
por: Makedonov, Ilia, et al.
Publicado: (2023) -
Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review
por: Li, Ke Xuan, et al.
Publicado: (2021) -
Treatment of haemorrhoidal disease with micronized purified flavonoid fraction and sucralfate ointment
por: Amaturo, Antonino, et al.
Publicado: (2020) -
Micronized Purified Flavonoid Fraction in Hemorrhoid Disease: A Systematic Review and Meta-Analysis
por: Sheikh, Parvez, et al.
Publicado: (2020) -
The Benefits of Micronized Purified Flavonoid Fraction (MPFF) Throughout the Progression of Chronic Venous Disease
por: Nicolaides, Andrew N.
Publicado: (2020)